On September 9, 2026, certolizumab pegol received FDA Breakthrough Therapy Designation for APS pregnancy; Jane E. Salmon, MD, reviews the IMPACT trial results behind it.
|Slideshows|August 12, 2021
National Breastfeeding Month 2021: August 12
August is National Breastfeeding Awareness Month. Join us throughout the month as we share statistics, facts, patient and provider resources, and more.
Advertisement
Reference
- Centers for Disease Control and Prevention. Breastfeeding Report Card, 2020. Centers for Disease Control and Prevention. Published September 2020. Accessed August 1, 2021.
https://www.cdc.gov/breastfeeding/data/reportcard.htm
Advertisement
Related to this article
Garima Sharma, MD, outlines validated cardiac risk scores for antenatal screening and the postpartum transitions needed to keep high-risk patients from being lost to follow-up.
Anti-CGRP antibody exposure in early pregnancy was linked to higher spontaneous abortion risk; propranolol was not.
HPV vaccination before pregnancy was linked to lower odds of preterm birth in a Swedish study of 624,713 births.
A new 3-part Lancet series reframes pregnancy as a cardiovascular risk window.
Wen Shen, MD, explains how clinicians can counter menopause misinformation from social media and steer patients toward evidence-based resources.
Wen Shen, MD, outlines when to treat perimenopausal symptoms and which history-taking red flags should prompt earlier bone and cardiovascular screening or referral.
Maternal high egg and peanut intake in pregnancy and lactation did not lower infant IgE-mediated egg or peanut allergy at 1 year in PrEggNut.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
FDA approves pritelivir tablets to treat lesions from HSV
2
Anti-CGRP antibodies associated with higher spontaneous abortion risk
3
Jane E. Salmon, MD, on the IMPACT trial of certolizumab pegol for adverse pregnancy outcomes in APS
4
Psychotherapy in menopause care: Addressing fear, anxiety, and GSM
5